Prospective diagnostic efficiency of biopsy washing DNA GSTP1 island hypermethylation for detection of adenocarcinoma of the prostate

被引:8
|
作者
Eilers, Tyark
Machtens, Stefan
Tezval, Hossein
Blaue, Christoph
Lichtinghagen, Ralf
Hagemann, Joern
Jonas, Udo
Serth, Juergen
机构
[1] Hannover Med Sch, Dept Urol, D-30625 Hannover, Germany
[2] Hannover Med Sch, Dept Clin Chem, D-30625 Hannover, Germany
来源
PROSTATE | 2007年 / 67卷 / 07期
关键词
prostate cancer; GSTP1; hypermethylation; biopsy washing; diagnostic; efficacy;
D O I
10.1002/pros.20546
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND. The prospective diagnostic efficiency of quantitative glutathione S transferase (GSTP1) promoter hypermethylation analysis in biopsy washing samples has not been determined so far. METHODS. Biopsies were obtained prospectively from 86 patients suspicious for Prostate cancer (CaP). After isolation of DNA from biopsy washings and bisulfite conversion methylated and unmethylated GSTP1 sequences were specifically quantitated by real-time fluorescence PCR. Relative degrees of methylation were compared to results of histopathological examination. RESULTS. Increased relative methylation was found for the CaP group (mean 28.1%) compared to biopsies without histological evidence for malignancy (5.2%; P < 0.001). A sensitivity and specificity of 92% and 86% and positive and negative predictive values of 82% and 94% were obtained. Receiver operating characteristic (ROC) analysis demonstrated a value of 0.90 (95% CI 0.82-0.98) for the area under curve (AUC). CONCLUSIONS. Biopsy washing DNA GSTP1 hypermethylation analysis demonstrates a high diagnostic efficacy which is comparable to the retrospective analysis of biopsy tissue specimens. Moreover it is compatible with routine biopsy examination thus permitting further prospective evaluation in CaP diagnosis.
引用
收藏
页码:757 / 763
页数:7
相关论文
共 50 条
  • [1] GSTP1 hypermethylation in prostate biopsy washing is a new biomarker for repeat prostate biopsy
    Nakayama, Masashi
    Tsuzuki, Toyonori
    Mukai, Masatoshi
    Nagahara, Akira
    Oka, Daizo
    Nakai, Yasutomo
    Shiba, Masahiro
    Takayama, Hitoshi
    Inoue, Hitoshi
    Nishimura, Kazuo
    Nelson, William G.
    De Marzo, Angelo M.
    Nonomura, Norio
    Okuyama, Akihiko
    [J]. JOURNAL OF UROLOGY, 2008, 179 (04): : 604 - 604
  • [2] GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas
    Tchou, JC
    Lin, XH
    Freije, D
    Isaacs, WB
    Brooks, JD
    Rashid, A
    De Marzo, AM
    Kanai, Y
    Hirohashi, S
    Nelson, WG
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2000, 16 (04) : 663 - 676
  • [3] GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells
    Lin, XH
    Tascilar, M
    Lee, WH
    Vles, WJ
    Lee, BH
    Veeraswamy, R
    Asgari, K
    Freije, D
    van Rees, B
    Gage, WR
    Bova, GS
    Isaacs, WB
    Brooks, JD
    DeWeese, TL
    De Marzo, AM
    Nelson, WG
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (05): : 1815 - 1826
  • [4] Minimally invasive detection of prostate cancer by GSTP1 hypermethylation
    Dumache, Raluca
    Motoc, Marilena
    Ionescu, Daniela
    Negru, Serban
    Kaycsa, Adriana
    David, Dana
    Puiu, Maria
    [J]. TOXICOLOGY LETTERS, 2012, 211 : S207 - S207
  • [5] GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer
    Nakayama, M
    Gonzalgo, ML
    Yegnasubramanian, S
    Lin, XH
    De Marzo, AM
    Nelson, WG
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2004, 91 (03) : 540 - 552
  • [6] Molecular detection of prostate cancer in urine by GSTP1 hypermethylation
    Cairns, P
    Esteller, M
    Herman, JG
    Schoenberg, M
    Jeronimo, C
    Sanchez-Cespedes, M
    Chow, NH
    Grasso, M
    Wu, L
    Westra, WB
    Sidransky, D
    [J]. CLINICAL CANCER RESEARCH, 2001, 7 (09) : 2727 - 2730
  • [7] Molecular detection of prostate cancer:: A role for GSTP1 hypermethylation
    Henrique, R
    Jerónimo, C
    [J]. EUROPEAN UROLOGY, 2004, 46 (05) : 660 - 669
  • [8] GSTP1 CpG island hypermethylation as a molecular marker in the carcinogenesis of prostate cancer
    Bastian, PJ
    Nakayama, M
    De Marzo, AM
    Nelson, WG
    [J]. UROLOGE A, 2004, 43 (05): : 573 - +
  • [9] Optimal use of a panel of methylation markers with GSTP1 hypermethylation in the diagnosis of prostate adenocarcinoma
    Tokumaru, Y
    Harden, SV
    Sun, DI
    Yamashita, K
    Epstein, JI
    Sidransky, D
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (16) : 5518 - 5522
  • [10] CPG island hypermethylation of the GSTP1 promoter in normal, proliferative inflammatory atrophy, high-grade PIN and adenocarcinoma of the prostate
    Nakayama, M
    Bennett, C
    Nelson, WG
    De Marzo, AM
    [J]. JOURNAL OF UROLOGY, 2002, 167 (04): : 134 - 135